Compared with the control group, monotherapy with OBP-702 significantly suppressed the growth of PAN02 tumors, whereas monotherapy with anti-PD-1 antibody did not suppress tumor growth (Figure 6A). This evidence concerns the gene PDCD1 and neoplasm.